Scott Henry analyst ALLIANCE GLOBAL PARTNERS

Currently out of the existing stock ratings of Scott Henry, 75 are a BUY (82.42%), 16 are a HOLD (17.58%).

Scott Henry

Work Performance Price Targets & Ratings Chart

Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 52.59% that have a potential upside of 49.27% achieved within 303 days. Previously, Scott Henry worked at ROTH.

Scott Henry’s has documented 180 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VVOS, Vivos Therapeutics  at 18-Nov-2024.

Wall Street Analyst Scott Henry

Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.

Average potential price target upside

ANIP ANI Pharmaceuticals CPRX Catalyst Pharmaceuticals CSBR Champions Oncology DCTH Delcath Systems LCI Lannett Company LGND Ligand Pharmaceuticals MYO Myomo RDHL Redhill Biopharma Ltd TNXP Tonix Pharmaceuticals Holding Corp VVOS Vivos Therapeutics  AVDL Avadel Pharmaceuticals PLC BDSI BioDelivery Sciences International IRM Iron Mountain LMAT LeMaitre Vascular REPH Recro Pharma INVO INVO Bioscience TTNP Titan Pharmaceuticals ZSAN Zosano Pharma Corp ZYNE Zynerba Pharmaceuticals SRTS Sensus Healthcare VKTX Viking Therapeutics IONM Assure Holdings Corp ASRT Assertio Therapeutics DERM Journey Medical Corp INM InMed Pharmaceuticals KMPH KemPharm NTEC Intec Pharma Ltd SOLY Soliton RVPH Reviva Pharmaceuticals Holdings RNXT RenovoRx INDP Indaptus Therapeutics NBY NovaBay Pharmaceuticals VERO Venus Concept

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$121

$26.76 (28.40%)

$84

1 months 10 days ago
(16-Sep-2025)

4/5 (80%)

$25.64 (26.89%)

671

Buy

$114

$19.76 (20.97%)

$86

1 months 19 days ago
(07-Sep-2025)

10/11 (90.91%)

$18.8 (19.75%)

291

Hold

$77

$-17.24 (-18.29%)

$65

2 months 16 days ago
(10-Aug-2025)

10/11 (90.91%)

$-7.88 (-9.28%)

372

Buy

$94

$-0.24 (-0.25%)

$94

7 months 10 days ago
(16-Mar-2025)

13/13 (100%)

$29.65 (46.08%)

317

Buy

$83

$-11.24 (-11.93%)

$49

1 years 1 months 9 days ago
(17-Sep-2024)

12/12 (100%)

$21.95 (35.95%)

597

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Scott Henry?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?